ArticleAsian Pacific journal of cancer prevention : APJCP2026
Evaluation of Pathological Complete Response Rate in Patients with HER2-Positive Breast Cancer Undergoing Neoadjuvant Trastuzumab and Chemotherapy With or Without Anthracycline.
Iago Mateus Rocha et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.